Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Parallel-Group, Double-blind, Placebo-controlled Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma
Conditions
Interventions
CC-5013
Dexamethasone
Locations
49
United States
Clinical Research Consultants, Inc.
Hoover, Alabama, United States
City of Hope National Medical Center
Duarte, California, United States
UCLA School of Medicine
Los Angeles, California, United States
UCSF California
San Francisco, California, United States
Stanford University Medical Center, Division of Hematology
Stanford, California, United States
Yale University School of Medicine
New Haven, Connecticut, United States
Start Date
January 1, 2003
Primary Completion Date
November 1, 2005
Completion Date
October 1, 2008
Last Updated
October 19, 2017
NCT06152575
NCT06179888
NCT04973605
NCT05201781
NCT05862012
NCT06138275
Lead Sponsor
Celgene
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions